Global Plasma Market 2012-2016

TechNavio's analysts forecast the Global Plasma market to grow at a CAGR of 10.31 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in the aging population. The Global Plasma market has also been witnessing the trend of increasing market consolidation. However, stringent regulations could pose a challenge to the growth of this market.

TechNavio's report, the Global Plasma Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global plasma market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space CSL Behring LLC, Baxter International Inc., Grifols S.A., and Octapharma AG

Other vendors mentioned in the report are Kedrion S.p.A., Biotest AG, Sanguine Corp., Cangene bioPharma Inc., Haemacure Corp., Kamada Inc., Omrix Biopharmaceuticals Inc., Vivostat A/S, Pfizer Inc., AstraZeneca plc, Takeda Pharmaceutical Inc., Novo Nordisk A/S, sanofi S.A., China Biologic Products Inc., Beijing Tiantan Biological Products Co. Ltd., Bharat Serums and Vaccines Ltd., and LFB Group.

Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?

01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
03.1Product Offerings
04. Market Landscape
04.1Market Size and Forecast
04.2Global Plasma Market by Plasma Derivative Segmentation
04.3Five Force Analysis
05. Geographical Segmentation
06. Vendor Landscape
06.1Global Plasma Market
06.2Global Immunoglobulin Market
06.3Global Albumin Market
Product Portfolio Matrix
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 Baxter International Inc.
Business Overview
Key Information
SWOT Analysis
13.2 CSL Behring LLC
Business Overview
Key Information
SWOT Analysis
13.3 Grifols S.A.
Business Overview
Key Information
SWOT Analysis
13.4 Octapharma AG
Business Overview
Key Information
SWOT Analysis
14. Other Reports in this Series

List of Exhibits:
Exhibit 1: Composition of Blood Plasma
Exhibit 2: Global Plasma Market 2012-2016 (US$ billion)
Exhibit 3: Global Plasma Market by Plasma Derivative Segmentation
Exhibit 4: Global Plasma Market by Plasma Derivative Segmentation 2012
Exhibit 5: Global Plasma Market by Geographical Segmentation 2012
Exhibit 6: Global Plasma Market by Vendor Segmentation 2012
Exhibit 7: Global Immunoglobulin Market by Vendor Segmentation 2012
Exhibit 8: Global Albumin Market by Vendor Segmentation 2012
Exhibit 9: Business Segmentation of Baxter International Inc.
Exhibit 10: Business Segmentation of Grifols S.A.
Exhibit 11: Business Segmentation of Octapharma AG